Ceptaris Therapeutics

Ceptaris Therapeutics

Verified
Pharmaceutical company developing therapeutics for symptoms of early-stage mycosis fungoides
  • Edit
DateInvestorsAmountRound
-N/A-
Not yet verified
N/A$750kSeries A
N/A$500kEarly VC
Not yet verified
$4.5mSeries B
$14.5mSeries C
Not yet verified
N/A$3.1mEarly VC
Not yet verified
N/AN/AEarly VC
Not yet verified
N/A$14.4mSeries D
Not yet verified
$15mDebt
$10mSeries D
$250m
Valuation: $250m
Acquisition
Total Funding$15.3m

Recent News about Ceptaris Therapeutics

Edit